Title : A phase I/II study of gemcitabine during radiotherapy in children with newly diagnosed diffuse intrinsic pontine glioma.

Pub. Date : 2017 Nov

PMID : 28748343






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Classifying patients according to the recently developed DIPG survival prediction model, intermediate risk patients (n = 4), showed a PFS and MOS of 6.4 and 12.4 months, respectively, versus a PFS and MOS of 4.5 and 8.1 months, respectively, in high risk patient (n = 5). Dipinacoline glutamate MOS proto-oncogene, serine/threonine kinase Homo sapiens